Company number 09434386
Status Active
Incorporation Date 11 February 2015
Company Type Private Limited Company
Address 2 FOSSEWAY COURT, LINCOLN, UNITED KINGDOM, LN6 8FG
Home Country United Kingdom
Nature of Business 26511 - Manufacture of electronic measuring, testing etc. equipment, not for industrial process control
Phone, email, etc
Since the company registration seven events have happened. The last three records are Confirmation statement made on 11 February 2017 with updates; Accounts for a dormant company made up to 28 February 2016; Annual return made up to 11 February 2016 with full list of shareholders
Statement of capital on 2016-02-25
GBP 200
. The most likely internet sites of DIAG-NOSE BIOTECHTRONICS LIMITED are www.diagnosebiotechtronics.co.uk, and www.diag-nose-biotechtronics.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and ten months. Diag Nose Biotechtronics Limited is a Private Limited Company.
The company registration number is 09434386. Diag Nose Biotechtronics Limited has been working since 11 February 2015.
The present status of the company is Active. The registered address of Diag Nose Biotechtronics Limited is 2 Fosseway Court Lincoln United Kingdom Ln6 8fg. The company`s financial liabilities are £0.19k. It is £0.19k against last year. And the total assets are £0.19k, which is £0.19k against last year. HALEY, Andrew Mark is a Director of the company. BWT INVESTMENT GROUP LIMITED is a Director of the company. Director TROSKIE, Allison has been resigned. The company operates in "Manufacture of electronic measuring, testing etc. equipment, not for industrial process control".
diag-nose biotechtronics Key Finiance
LIABILITIES
£0.19k
CASH
n/a
TOTAL ASSETS
£0.19k
All Financial Figures
Current Directors
Director
BWT INVESTMENT GROUP LIMITED
Appointed Date: 11 February 2015
Resigned Directors
Director
TROSKIE, Allison
Resigned: 01 April 2015
Appointed Date: 11 February 2015
66 years old
Persons With Significant Control
Bwt Investment Group Ltd
Notified on: 1 January 2017
Nature of control: Ownership of shares – More than 25% but not more than 50%
DIAG-NOSE BIOTECHTRONICS LIMITED Events
24 Feb 2017
Confirmation statement made on 11 February 2017 with updates
31 Oct 2016
Accounts for a dormant company made up to 28 February 2016
25 Feb 2016
Annual return made up to 11 February 2016 with full list of shareholders
Statement of capital on 2016-02-25
23 Apr 2015
Termination of appointment of Allison Troskie as a director on 1 April 2015
11 Mar 2015
Appointment of Mr Andrew Mark Haley as a director on 11 March 2015
11 Feb 2015
Director's details changed for Alison Troskie on 11 February 2015
11 Feb 2015
Incorporation
Statement of capital on 2015-02-11